About this trial
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients of all genders must be at least 18 years of age.
Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
Patients must be able to complete questionnaires in English.
Disqualifiers
Patients who are < 18 years of age are not eligible.
Patients who are Pregnant are not eligible.
Trial design
Parallel
Treatments tested in this trial
health services intervention
Other interventionHealth services intervention
Treatment groups
Trial outcomes
Primary outcomes
Patient reported outcomes
Symptom burden based on patient reporting on Brain Mets Symptom Inventory
Secondary outcomes
Feasibility
Number of % of patients able to complete protocol-specified activities
Patient understanding of prognosis
Concordance with physician predication of prognosis
survival
Survival outcomes for patients receiving best supportive care
Other outcomes
Exploratory survival outcome
90 day and 1 year survival
Sponsors and contacts
Click on the lead sponsor to view all of their trials.